Conference Description:

As the demand for information outside of approved labeling continues to rise, the FDA has been called by the industry to provide guidance that governs off-label communications. The regulatory landscape that monitors this space is often blamed for limiting the amount of information received by patients and restricting their ability to make well-informed decisions.

Given the public health issues at stake and the public interest involved, it is imperative that this event details the importance of the timely communication of truthful scientific information that currently challenges pharmaceutical, biotech, and medical device professionals. The 2018 Off-Label Regulatory Compliance Congress also explores the ever-changing regulatory landscape and explains how professionals can work with officials to ensure that promotional practices remain compliant and expedite the transmission of relevant scientific information to advance public health.

URLs:
Booking: https://go.evvnt.com/197360-1?pid=154
Brochure: https://go.evvnt.com/197360-2?pid=154

Time: 08:00 to 17:00

Price:
Early Bird Pricing - Register by April 6, 2018: USD 1895,
Standard Pricing: USD 2095,
Onsite Pricing: USD 2295

Speakers: Sergio Alegre, Vice President, Global Compliance, OSMOTICA PHARMACEUTICALS, Richard Lem, Assistant Director, Regulatory Affairs - Advertising and Promotion, BAYER HEALTHCARE